FDA to Ease Copycat Drug Rules, Speeding Access to Cheaper Drugs
FRIDAY, Oct. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to cheaper alternatives. The decision affects biosimilars — medicines that are near-identical copiesContinue Reading










